TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
出版年份 2019 全文链接
标题
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
作者
关键词
Galunisertib, TGF-β1, CA19-9, Pancreatic cancer
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-03-18
DOI
10.1007/s00280-019-03807-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
- (2018) Davide Melisi et al. BRITISH JOURNAL OF CANCER
- MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition
- (2017) Chengyuan Ma et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weeklynab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
- (2016) E. G. Chiorean et al. ANNALS OF ONCOLOGY
- T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression
- (2016) Scott J. Patterson et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Single-stranded DNA binding protein Ssbp3 induces differentiation of mouse embryonic stem cells into trophoblast-like cells
- (2016) Jifeng Liu et al. Stem Cell Research & Therapy
- Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition
- (2015) Xiao Xiao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A regression tree approach to identifying subgroups with differential treatment effects
- (2015) Wei-Yin Loh et al. STATISTICS IN MEDICINE
- Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes
- (2015) Kelly E. Craven et al. Oncotarget
- IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
- (2015) Serena Lunardi et al. Oncotarget
- Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
- (2014) Richard J. Kovacs et al. Cardiovascular Toxicology
- First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
- (2014) Jordi Rodon et al. CLINICAL CANCER RESEARCH
- Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
- (2014) MAKOTO ABUE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of osteopontin in the pathophysiology of cancer
- (2014) Lalita A. Shevde et al. MATRIX BIOLOGY
- The MicroRNA 424/503 Cluster Reduces CDC25A Expression during Cell Cycle Arrest Imposed by Transforming Growth Factor in Mammary Epithelial Cells
- (2014) D. Llobet-Navas et al. MOLECULAR AND CELLULAR BIOLOGY
- Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
- (2014) Milind Javle et al. PLoS One
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma
- (2013) Jiong Chen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-β1
- (2013) Mi-Young Moon et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
- (2013) H Ouyang et al. ONCOGENE
- MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer
- (2013) Kemin Wu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) T. Seufferlein et al. ANNALS OF ONCOLOGY
- Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells
- (2012) Monica Lupu-Meiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miR-148b Functions as a Tumor Suppressor in Pancreatic Cancer by Targeting AMPK 1
- (2012) G. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
- (2012) Peng Wang et al. Molecular Oncology
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes
- (2010) Sanna Rosengren et al. ARTHRITIS RESEARCH & THERAPY
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
- (2009) Thomas Greither et al. INTERNATIONAL JOURNAL OF CANCER
- Randomization by minimization for unbalanced treatment allocation
- (2009) Baoguang Han et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search